Acne Vulgaris
Understanding Acne Vulgaris (common acne, pimples): Find information on diagnosis, clinical documentation, and medical coding for acne. This resource covers healthcare best practices, treatment options, and ICD-10 codes related to Acne Vulgaris for accurate medical records and billing. Learn about the causes, symptoms, and management of pimples and common acne for improved patient care.
Inflammatory skin condition causing pimples, blackheads, and whiteheads.
Comedones, papules, pustules, nodules, cysts on face, chest, and back.
Primary care, dermatology, telehealth consultations.
ICD-10 Code Families
Complete code families applicable to L70.0
When to use each related code
| Description | When to use |
|---|---|
| Inflammatory skin condition with pimples, blackheads, etc. | Use for common acne affecting face, chest, or back. Consider severity (mild, moderate, severe). |
| Severe form of acne with nodules and cysts. | Use for acne with deep, painful lesions. Often leaves scars. Code with associated severity. |
| Acne-like rash triggered by medication. | Use when acne develops after starting a new medication like corticosteroids or lithium. |
Best-practice checklist
- ✓Acne vulgaris ICD-10 code (e.g., L70.0)
- ✓Document lesion morphology (e.g., comedones, papules)
- ✓Location and distribution of acne (e.g., facial, back)
- ✓Severity assessment (e.g., mild, moderate, severe)
- ✓Treatment plan documentation (e.g., topical retinoids)
Common pitfalls to avoid
Coding acne vulgaris without specifying the type (e.g., comedonal, inflammatory) may lead to claim denials or underpayment. CDI should clarify.
Inaccurate coding of acne severity (mild, moderate, severe) impacts reimbursement and quality metrics. Audits focus on supporting documentation.
Lack of documentation supporting the medical necessity of acne treatment can trigger audits and claim rejections. CDI can improve documentation.
Best-practice tips
- 01Gentle cleansing, avoid harsh scrubbing. ICD-10: L70.0
- 02Topical retinoids, benzoyl peroxide. CPT: 90784
- 03Oral antibiotics for moderate/severe acne. CDI: Inflammation documentation
- 04Limit sun exposure, non-comedogenic products. HCC: Risk adjustment
- 05Isotretinoin for severe cases, monitor side effects. Compliance: Patient education
Step-by-step checklist
- 1
Confirm open/closed comedones, papules, pustules, nodules present
- 2
Rule out rosacea, folliculitis, perioral dermatitis
- 3
Assess severity (mild, moderate, severe) based on lesion count/type
- 4
Document lesion location (face, back, chest, etc.)
- 5
Check for scarring, hyperpigmentation
Ready-to-paste narrative
Patient presents with acne vulgaris, also known as common acne or pimples, characterized by comedones, papules, pustules, and nodules. The affected areas include the face, chest, and back. The patient reports onset during adolescence and describes the acne as inflammatory and occasionally painful. Severity is assessed as moderate based on lesion count and distribution. Differential diagnosis includes rosacea, folliculitis, and perioral dermatitis. No personal or family history of keloid formation was noted. Current skincare regimen includes over-the-counter benzoyl peroxide wash. The patient denies picking or squeezing lesions. Treatment plan includes topical retinoid cream (tretinoin 0.025%) applied nightly, along with continued use of benzoyl peroxide. Patient education provided regarding acne skincare, including proper cleansing techniques and the importance of adherence to the prescribed treatment regimen. Discussed potential side effects of tretinoin, including dryness and irritation. Scheduled follow-up appointment in four weeks to assess treatment efficacy and adjust the plan as needed. ICD-10 code L70.0, acne vulgaris, assigned. Medical billing codes for evaluation and management, as well as topical medication dispensing, will be applied based on time spent and services rendered during the visit. Patient expresses understanding of the treatment plan and acknowledges potential side effects. Prognosis is good with consistent treatment.
Common questions and answers
What are the most effective evidence-based treatment strategies for moderate to severe acne vulgaris in adult female patients?+
For moderate to severe acne vulgaris in adult females, evidence-based treatment strategies often involve a combination approach. Topical retinoids, like tretinoin or adapalene, are considered first-line therapy and help regulate skin cell turnover. Combined oral contraceptives containing ethinyl estradiol and a progestin like drospirenone or norgestimate can be highly effective in managing hormonally-influenced acne. For more severe cases or those resistant to other treatments, oral antibiotics such as doxycycline or minocycline may be prescribed for a limited period, always considering antibiotic stewardship. Spironolactone, an anti-androgen medication, can also be beneficial for women, particularly those experiencing flares related to their menstrual cycle. Isotretinoin remains a highly effective option for severe, recalcitrant acne but requires careful monitoring due to its potential side effects. Explore how combination therapy can be tailored to individual patient needs and consider implementing strategies for managing potential side effects to improve patient adherence and outcomes. Learn more about the latest clinical guidelines for acne management in adult women.
How can I differentiate between acne vulgaris and rosacea in patients presenting with similar inflammatory papules and pustules?+
Differentiating between acne vulgaris and rosacea can be challenging when patients present with overlapping symptoms like inflammatory papules and pustules. Key clinical features can help distinguish the two conditions. Acne vulgaris typically involves comedones (blackheads and whiteheads), which are absent in rosacea. Rosacea often presents with centrofacial erythema (redness) and telangiectasia (visible blood vessels), while these are not characteristic of acne. Flushing and burning sensations are more common in rosacea. While both conditions can involve papules and pustules, their distribution can differ. Acne tends to affect areas with higher sebaceous gland density, while rosacea primarily affects the central face. A thorough patient history, including triggers and symptom patterns, can aid in the differential diagnosis. Consider implementing standardized assessment tools for both acne and rosacea to ensure accurate diagnosis and appropriate treatment selection. Learn more about the clinical features and diagnostic criteria for differentiating these conditions.
What are the recommended best practices for minimizing acne scarring and post-inflammatory hyperpigmentation (PIH) during and after acne treatment?+
Minimizing acne scarring and post-inflammatory hyperpigmentation (PIH) requires a proactive approach during and after acne treatment. Early and effective acne management is crucial for preventing scar formation. Gentle skincare practices, including avoiding harsh scrubbing and picking at lesions, are essential. Sun protection is paramount, as UV exposure can exacerbate PIH and worsen scarring. Topical retinoids can help reduce PIH and improve skin texture, while ingredients like azelaic acid and niacinamide can also be beneficial for addressing hyperpigmentation. For deeper scars, procedures such as chemical peels, microneedling, and laser therapy may be considered. Patient education on proper skincare and scar prevention strategies is vital for optimal outcomes. Explore how different treatment modalities and skincare ingredients can be integrated to address both acne and its potential sequelae. Consider implementing a comprehensive scar management plan that includes both preventative measures and targeted treatments for existing scars and PIH.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.